88 related articles for article (PubMed ID: 20823157)
21. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of monocyte-derived dendritic cells under the influence of platelets.
Nguyen XD; Müller-Berghaus J; Kälsch T; Schadendorf D; Borggrefe M; Klüter H
Cytotherapy; 2008; 10(7):720-9. PubMed ID: 18985478
[TBL] [Abstract][Full Text] [Related]
23. A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma.
Chang GC; Lan HC; Juang SH; Wu YC; Lee HC; Hung YM; Yang HY; Whang-Peng J; Liu KJ
Cancer; 2005 Feb; 103(4):763-71. PubMed ID: 15637694
[TBL] [Abstract][Full Text] [Related]
24. A functional comparison of mature human dendritic cells prepared in fluorinated ethylene-propylene bags or polystyrene flasks.
Kurlander RJ; Tawab A; Fan Y; Carter CS; Read EJ
Transfusion; 2006 Sep; 46(9):1494-504. PubMed ID: 16965575
[TBL] [Abstract][Full Text] [Related]
25. Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.
Nukiwa M; Andarini S; Zaini J; Xin H; Kanehira M; Suzuki T; Fukuhara T; Mizuguchi H; Hayakawa T; Saijo Y; Nukiwa T; Kikuchi T
Eur J Immunol; 2006 Apr; 36(4):1019-27. PubMed ID: 16525992
[TBL] [Abstract][Full Text] [Related]
26. The optimal interval for dendritic cell vaccination following adoptive T cell transfer is important for boosting potent anti-tumor immunity.
Park MY; Kim CH; Sohn HJ; Oh ST; Kim SG; Kim TG
Vaccine; 2007 Oct; 25(42):7322-30. PubMed ID: 17889413
[TBL] [Abstract][Full Text] [Related]
27. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity.
Tatsumi T; Huang J; Gooding WE; Gambotto A; Robbins PD; Vujanovic NL; Alber SM; Watkins SC; Okada H; Storkus WJ
Cancer Res; 2003 Oct; 63(19):6378-86. PubMed ID: 14559827
[TBL] [Abstract][Full Text] [Related]
28. Fucoidan stimulation induces a functional maturation of human monocyte-derived dendritic cells.
Yang M; Ma C; Sun J; Shao Q; Gao W; Zhang Y; Li Z; Xie Q; Dong Z; Qu X
Int Immunopharmacol; 2008 Dec; 8(13-14):1754-60. PubMed ID: 18783737
[TBL] [Abstract][Full Text] [Related]
29. Delivery of interferon-alpha transfected dendritic cells into central nervous system tumors enhances the antitumor efficacy of peripheral peptide-based vaccines.
Okada H; Tsugawa T; Sato H; Kuwashima N; Gambotto A; Okada K; Dusak JE; Fellows-Mayle WK; Papworth GD; Watkins SC; Chambers WH; Potter DM; Storkus WJ; Pollack IF
Cancer Res; 2004 Aug; 64(16):5830-8. PubMed ID: 15313927
[TBL] [Abstract][Full Text] [Related]
30. Sinomenine promotes differentiation but impedes maturation and co-stimulatory molecule expression of human monocyte-derived dendritic cells.
Chen Y; Yang C; Jin N; Xie Z; Fei L; Jia Z; Wu Y
Int Immunopharmacol; 2007 Aug; 7(8):1102-10. PubMed ID: 17570327
[TBL] [Abstract][Full Text] [Related]
31. Human dendritic cell mediated cytotoxicity against breast carcinoma cells in vitro.
Manna PP; Mohanakumar T
J Leukoc Biol; 2002 Aug; 72(2):312-20. PubMed ID: 12149422
[TBL] [Abstract][Full Text] [Related]
32. Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration.
Teitz-Tennenbaum S; Li Q; Rynkiewicz S; Ito F; Davis MA; McGinn CJ; Chang AE
Cancer Res; 2003 Dec; 63(23):8466-75. PubMed ID: 14679011
[TBL] [Abstract][Full Text] [Related]
33. Dendritic cells incubated with irradiated tumor cells effectively stimulate T lymphocyte activation and induce enhanced expression of CD69, CD25 as well as production of IFNgamma and IL4.
Stegel V; Kopitar A; Jezersek Novaković B; Ihan A; Novaković S
Int Immunopharmacol; 2006 Jan; 6(1):79-89. PubMed ID: 16332516
[TBL] [Abstract][Full Text] [Related]
34. Neem leaf glycoprotein matures myeloid derived dendritic cells and optimizes anti-tumor T cell functions.
Goswami S; Bose A; Sarkar K; Roy S; Chakraborty T; Sanyal U; Baral R
Vaccine; 2010 Feb; 28(5):1241-52. PubMed ID: 19969119
[TBL] [Abstract][Full Text] [Related]
35. HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity.
Yin R; Zheng W; Hao F; Yang XC; Zhong BY; Li QJ
J Dermatol Sci; 2009 Aug; 55(2):116-22. PubMed ID: 19500947
[TBL] [Abstract][Full Text] [Related]
36. Fusion of CpG-ODN-stimulating dendritic cells with Lewis lung cancer cells can enhance anti-tumor immune responses.
Du YC; Lin P; Zhang J; Lu YR; Ning QZ; Wang Q
Tissue Antigens; 2006 May; 67(5):368-76. PubMed ID: 16671943
[TBL] [Abstract][Full Text] [Related]
37. [Immunotherapy against tumor with dendritic cell sensitized by necrotic tumor tissue after microwave coagulation therapy].
Yao LC; Yang RJ
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2552-6. PubMed ID: 18067832
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling and functional activity of human dendritic cells induced with IFN-alpha-2b: implications for cancer immunotherapy.
Moschella F; Bisikirska B; Maffei A; Papadopoulos KP; Skerrett D; Liu Z; Hesdorffer CS; Harris PE
Clin Cancer Res; 2003 Jun; 9(6):2022-31. PubMed ID: 12796364
[TBL] [Abstract][Full Text] [Related]
39. Species-specific properties and translational aspects of canine dendritic cells.
Qeska V; Baumgärtner W; Beineke A
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):181-92. PubMed ID: 23280245
[TBL] [Abstract][Full Text] [Related]
40. [Anti-tumor immunotherapy based on dendritic cells].
Toungouz M; Lambermont M; Velu T; Buelens C; Vanderheyde N; Bartholomé E; Willems F; Gangji D; Goldman M
J Soc Biol; 2001; 195(1):19-23. PubMed ID: 11530495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
